Schroder Investment Management Group Catalyst Pharmaceuticals, Inc. Transaction History

Schroder Investment Management Group

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	BUY	$14.34 - $21.05 $3.98 Million - $5.84 Million	277,515 New	277,515 $4.6 Million
Q2 2021 Aug 13, 2021	SELL	$4.29 - $6.05 $3.29 Million - $4.64 Million	-767,041 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$3.45 - $4.69 $501,926 - $682,329	-145,486 Reduced 15.94%	767,041 $3.54 Million
Q4 2020 Feb 16, 2021	SELL	$2.97 - $3.83 $341,134 - $439,913	-114,860 Reduced 11.18%	912,527 $3.05 Million
Q3 2020 Nov 13, 2020	SELL	$2.97 - $5.08 $1.86 Million - $3.17 Million	-624,824 Reduced 37.82%	1,027,387 $3.13 Million
Q2 2020 Aug 13, 2020	BUY	$3.48 - $5.05 $1.13 Million - $1.63 Million	323,645 Added 24.36%	1,652,211 $7.63 Million
Q1 2020 May 15, 2020	BUY	$2.61 - $5.21 $2.54 Million - $5.08 Million	974,809 Added 275.56%	1,328,566 $5.21 Million
Q4 2019 Feb 11, 2020	BUY	$3.67 - $5.7 $1.3 Million - $2.02 Million	353,757 New	353,757 $1.33 Million

327

94.1M

19.1K

51.1K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.33B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Schroder Investment Management Group, based on Form 13F filings with the SEC.

Stay updated on Schroder Investment Management Group with notifications on news.